Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,648.9
28.7 (1.10%)

 

  • STI Straits Times Index
    2,648.9
    28.7 (1.10%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,585.6
    -13.2 (-0.83%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    25,481.6
    3.7 (0.01%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,361.3
    -53.3 (-1.56%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,945.5
    358.5 (1.59%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,075.8
    -3.3 (-0.07%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,366.2M
  • Value: 1,138.6M
  • Rise: 196
  • Fall: 167
  • Unch: 447

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Rex Intl0.176+0.007
IX Biopharma0.285-0.030
Biolidics0.435-0.085
Singapore-eDev0.091-0.011
Hyphens Pharma0.420-0.060
Clearbridge0.186-0.002
QT Vascular0.008-
Medtecs Intl0.645+0.010
Genting Sing0.785+0.010
Singtel2.540+0.020

World Indices

World Indices
Name Last Change
Nasdaq 9,757.2 -259.8
HSI 24,246.6 -303.4
HSCEI 9,742.1 -111.1
Jakarta 4,863.1 -41.0
Nikkei 225 22,062.1 -450.0
SSE Comp 2,958.7 -11.9
Shanghai A 3,101.3 -12.4
Shanghai B 211.6 -1.8
KOSPI 2,098.0 -36.7

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

NOVA NOVA WELLNESS GROUP BERHAD
Quotes 15 Minutes Delayed. Updated at 15 Jul 2020 16:59
Last (MYR): 0.765 Change: +0.045 High: 0.770 Remarks:
Change (%): +6.25 Low: 0.730
Open 0.730 Yesterday's Close 0.720
Buy Price 0.765 Sell Price 0.770
Buy Volume ('00) 95 Sell Volume ('00) 2,425
Cumulative Volume ('00) 29,032 Cumulative Value 2,197,190
Click to show Stock Prices chart

Key Statistics

EPS (MYR) a 0.03444 Trailing EPS (MYR) e 0.04332 NAV (MYR) b 0.2569
PE a 22.213 Trailing PE f 17.657 Price / NAV b 2.9778
Dividend (MYR) d - Cash In Hand (MYR) g 0.0037 Issued & Paid-up Shares c 317,744,000
Dividend Yield (%) d - Price / Cash In Hand g 206.757 Treasury Shares h -
Beta - 75 Daysi 1.141 R-Squared - 75 Days(%)i 2.82 Market Cap (M) 243.074
Beta - 500 Daysi 1.251 R-Squared - 500 Days (%)i 8.18 Enterprise Value (M) 209.382
Piotroski F Score 7 Exchange Code 0201 Par Value ( $ ) n.a.
52 Weeks Volatility (%) 48.12 6-Month VWAP 0.684 Free Float (%) 25.7
Sector & Industry Health Technology - Pharmaceuticals: Major
Index Components BM HEALTH CARE
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 29 Oct 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 29 Oct 2019.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference NOVA Bursa 243.074 22.213 17.657 2.9778 -
Industry PHARMACEUTICALS Bursa 629.495 274.557 143.946 2.2705 2.327
Pharmaceuticals: Major Bursa 714.955 10.752 10.781 0.6323 0.657
Index BM HEALTH CARE Bursa 12,068.966 111.311 112.492 5.8607 0.395
Local Peer IGBB Bursa 2,344.703 11.237 13.255 0.6770 -
Local Peer BSTEAD Bursa 1,135.113 - - 0.3162 -
Local Peer PHARMA Bursa 711.840 - - 2.0339 3.119
Local Peer KOTRA Bursa 398.588 17.959 14.146 2.1924 2.673
Local Peer BIOHLDG Bursa 118.489 14.252 44.394 0.7216 -
Local Peer SUNZEN Bursa 52.877 - - 0.5956 -
Global Peer JOHNSON & JOHNSON NYSE 389,708.553 25.776 22.702 6.3580 2.533
Global Peer NOVARTIS AG ADR-EACH REPR 1 CHF0.5(REGD) NYSE 215,793.738 30.617 21.622 - -
Global Peer MERCK & CO INC NYSE 197,510.825 20.066 19.465 7.5372 2.905
Global Peer PFIZER INC NYSE 195,696.661 12.027 12.394 3.0103 4.129
Global Peer ABBVIE INC NYSE 174,242.556 22.219 20.765 -23.4985 3.726
Global Peer ELI LILLY AND COMPANY NYSE 156,839.387 33.817 28.345 50.9419 1.575
Global Peer ASTRAZENECA SPON ADR EACH REP 0.50 ORD SHS NYSE 141,672.669 105.684 190.488 - -
Global Peer BRISTOL-MYERS SQUIBB CO NYSE 130,987.124 38.089 137.303 2.6244 2.858
Global Peer SANOFI SPON ADR ECH REP 0.5 ORD SHS NASDAQ 130,920.122 40.238 40.238 1.9790 2.248
Global Peer NOVO NORDISK A/S ADR-EACH CNV INTO 1 CLASS B DKK1 NYSE 118,704.554 20.329 19.756 14.8402 -
Other Global Peers GLAXOSMITHKLINE ADR EACH CNV INTO 2 ORD GBP0.25 (NYSE), TAKEDA PHARMACEUTICAL CO LTD SPON ADS EACH REP 0.5 ORD SHS (NYSE), WUXI APPTEC (HKEx), HANSOH PHARMA (HKEx), ROYALTY PHARMA PLC (NASDAQ), INNOVENT BIO (HKEx), SINOPHARM (HKEx), CANSINOBIO-B (HKEx), REPLIGEN CORP (NASDAQ), JUNSHI BIO (HKEx), SH PHARMA (HKEx), BAIYUNSHAN PH (HKEx), GRIFOLS SA SPON ADR EA REPR 1 ORD EUR0.10 (NASDAQ), REATA PHARMACEUTICALS INC (NASDAQ), LEGEND BIOTECH CORP SPON ADS EACH REP 2 ORD SHS (NASDAQ), HENLIUS-B (HKEx), BIOHAVEN PHARMACEUTICAL HLDG CO LTD (NYSE), NEKTAR THERAPEUTICS (NASDAQ), HUTCHISON CHINA MEDITECH SPON ADS EACH REPR 5 ORD SHS (NASDAQ), CHINARES PHARMA (HKEx), AKESO-B (HKEx), ALLAKOS INC (NASDAQ), HEPALINK (HKEx), CMS (HKEx), ADC THERAPEUTICS SA (NYSE), TRAD CHI MED (HKEx), OPKO HEALTH INC (NASDAQ), CHINAGRANDPHARM (HKEx), TURNING POINT THERAPEUTICS INC (NASDAQ), OCUMENSION-B (HKEx), INNOCARE-B (HKEx), KARUNA THERAPEUTICS INC (NASDAQ), APELLIS PHARMACEUTICALS INC (NASDAQ), HYGEIA HEALTH (HKEx), PRINCIPIA BIOPHARMA INC (NASDAQ), SSY GROUP (HKEx), IGM BIOSCIENCES INC (NASDAQ), I MAB SPON ADS EACH REP 2.3 ORD SHS (NASDAQ), UNITED LAB (HKEx), FORMA THERAPEUTICS HLDGS INC (NASDAQ), SPRINGWORKS THERAPEUTICS INC (NASDAQ), Y-MABS THERAPEUTICS INC (NASDAQ), ZYMEWORKS INC (NYSE), AMNEAL PHARMACEUTICALS INC (NYSE), CSTONE PHARMA-B (HKEx), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), CONSTELLATION PHARMACEUTICALS INC (NASDAQ), KINIKSA PHARMACEUTICALS LTD (NASDAQ), TRICIDA INC (NASDAQ), ODONATE THERAPEUTICS INC (NASDAQ), AKCEA THERAPEUTICS INC (NASDAQ), AKERO THERAPEUTICS INC (NASDAQ), CKLIFE SCIENCES (HKEx), ARCTURUS THERAPEUTICS HOLDINGS INC (NASDAQ), TONGRENTANGCM (HKEx), ARCUTIS BIOTHERAPEUTICS INC (NASDAQ), PHIBRO ANIMAL HEALTH CORP (NASDAQ), GOSSAMER BIO INC (NASDAQ), PETIQ INC (NASDAQ), ATHENEX INC (NASDAQ), IMMUNOTECH-B (HKEx), HUA MEDICINE-B (HKEx), PHATHOM PHARMACEUTICALS INC (NASDAQ), REPARE THERAPEUTICS INC (NASDAQ), GENERATION BIO CO (NASDAQ), KRYSTAL BIOTECH INC (NASDAQ), QUANTERIX CORPORATION (NASDAQ), G1 THERAPEUTICS IN (NASDAQ), ORIC PHARMACEUTICALS INC (NASDAQ), FUSION PHARMACEUTICALS INC (NASDAQ), PROVENTION BIO INC (NASDAQ), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), RELMADA THERAPEUTICS INC (NASDAQ), KEROS THERAPEUTICS INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), OYSTER POINT PHARMA INC (NASDAQ), APREA THERAPEUTICS INC (NASDAQ), CALLIDITAS THERAPEUTICS AB SPON ADS EACH REP 2 ORD SHS (NASDAQ), KALA PHARMACEUTICALS INC (NASDAQ), SHINEWAY PHARM (HKEx), Kimia Farma Tbk. (IDX), AC IMMUNE SA (NASDAQ), 89BIO INC (NASDAQ), CRINETICS PHARMACEUTICALS INC (NASDAQ), ORCHARD THERAPEUTICS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), FULCRUM THERAPEUTICS INC (NASDAQ), BIOSPECIFICS TECHNOLOGIES CORP (NASDAQ), MIRUM PHARMACEUTICALS INC (NASDAQ), SIGA TECHNOLOGIES INC (NASDAQ), OCULAR THERAPEUTIX INC (NASDAQ), SATSUMA PHARMACEUTICALS INC (NASDAQ), BEYONDSPRING INC (NASDAQ), DURECT CORP (NASDAQ), OVID THERAPEUTICS INC (NASDAQ), IMARA INC (NASDAQ), TCR2 THERAPEUTICS INC (NASDAQ), OSMOTICA PHARMACEUTICALS PLC (NASDAQ), IDEAYA BIOSCIENCES INC (NASDAQ), FUSEN PHARM (HKEx), TOT BIOPHARM-B (HKEx), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), AMRYT PHARMA PLC (NEW) SPON ADS EACH REP 5 ORD SHS (NASDAQ), BIONDVAX PHARMACEUTICALS SPON ADS REP 40 ORD SHS (NASDAQ), SUTRO BIOPHARMA INC (NASDAQ), AFT PHARMACEUTICALS LTD (ASX), STARPHARMA HOLDINGS LIMITED (ASX), UROVANT SCIENCES LTD (NASDAQ), SPERO THERAPEUTICS INC (NASDAQ), AMAG PHARMACEUTICS INC (NASDAQ), MENLO THERAPEUTICS INC (NASDAQ), LIQUIDIA TECHNOLOGIES INC (NASDAQ), PYC THERAPEUTICS LIMITED (ASX), HOOKIPA PHARMA INC (NASDAQ), POLYPID LTD (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), VERRICA PHARMACEUTICALS INC (NASDAQ), KALEIDO BIOSCIENCES INC (NASDAQ), KALVISTA PHARMACEUTICALS INC (NASDAQ), VERU INC (NASDAQ), SCPHARMACEUTICALS INC (NASDAQ), LANNETT CO INC (NYSE), GALERA THERAPEUTICS INC (NASDAQ), GAMIDA CELL LTD (NASDAQ), CH BIOTECH SER (HKEx), EVELO BIOSCIENCES INC (NASDAQ), NEUBASE THERAPEUTICS INC (NASDAQ), IMMUNIC INC (NASDAQ), SOL GEL TECHNOLOGIES LTD (NASDAQ), DAWNRAYS PHARMA (HKEx), LOGICBIO THERAPEUTICS INC (NASDAQ), THERATECHNOLOGIES INC (NASDAQ), MUSTANG BIO INC (NASDAQ), AVENUE THERAPEUTICS INC (NASDAQ), TYME TECHNOLOGIES INC (NASDAQ), PROTARA THERAPEUTICS INC (NASDAQ), OBSEVA SA (NASDAQ), GRITSTONE ONCOLOGY INC (NASDAQ), LYRA THERAPEUTICS INC (NASDAQ), IX Biopharma (SGX), AQUESTIVE THERAPEUTICS INC (NASDAQ), PHASEBIO PHARMACEUTICALS INC (NASDAQ), AYALA PHARMACEUTICALS INC (NASDAQ), CYCLERION THERAPEUTICS INC (NASDAQ), HARROW HEALTH INC (NASDAQ), XERIS PHARMACEUTICALS INC (NASDAQ), BIOMX INC (NYSE American), ESSA PHARMA INC (NASDAQ), ZHONGZHIPHARM (HKEx), TFF PHARMACEUTICALS INC (NASDAQ), GENPREX INC (NASDAQ), KITOV PHARMA LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), Merck Tbk. (IDX), RECCE PHARMACEUTICALS LTD (ASX), CORVUS PHARMACEUTICALS INC (NASDAQ), EVOLUS INC (NASDAQ), ETON PHARMACEUTICALS INC (NASDAQ), Hyphens Pharma (SGX), MEDIWOUND LTD (NASDAQ), APTORUM GROUP LIMITED (NASDAQ), CHECKPOINT THERAPEUTICS INC (NASDAQ), PAK FAH YEOW (HKEx), NEW RAY MEDIC (HKEx), TREVI THERAPEUTICS INC (NASDAQ), EYEPOINT PHARMACEUTICALS INC (NASDAQ), RACE ONCOLOGY LTD (ASX), THE FS ALSEC ALPHASECTOR (NASDAQ), MILESTONE PHARMACEUTICALS INC (NASDAQ), CHARMACY PHAR (HKEx), LANTERN PHARMA INC (NASDAQ), NC HEALTHCARE (HKEx), CLEARSIDE BIOMEDICAL INC (NASDAQ), Phapros Tbk. (IDX), ONCOSIL MEDICAL LIMITED (ASX), PALLA PHARMA LTD (ASX), ARIDIS PHARMACEUTICAL INC (NASDAQ), IP (SET), BAUDAX BIO INC (NASDAQ), AKARI THERAPEUTICS PLC SPON ADR EACH REPR 100 ORD (NASDAQ), ADDEX THERAPEUTICS LIMITED SPON ADS EACH REP 6 ORD SHS (NASDAQ), CITIUS PHARMACEUTICALS INC (NASDAQ), EYENOVIA INC (NASDAQ), AERPIO PHARMACEUTICALS INC (NASDAQ), NEP INTERLONG (HKEx), MOLECULIN BIOTECH INC (NASDAQ), ADAMIS PHARMACEUTICALS CORPORATION (NASDAQ), ALLENA PHARMACEUTICALS INC (NASDAQ), WAI YUEN TONG (HKEx), EDESA BIOTECH INC (NASDAQ), NOXOPHARM LTD (ASX), TBG DIAGNOSTICS LTD (ASX), MANNATECH INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), ONCTERNAL THERAPEUTICS INC (NASDAQ), NOVAN INC (NASDAQ), ANNOVIS BIO INC (NYSE American), PURAPHARM (HKEx), SANAI HEALTH GP (HKEx), HOTH THERAPEUTICS INC (NASDAQ), HISTOGEN INC (NASDAQ), INVION LTD (ASX), AGEX THERAPEUTICS INC (NYSE American), JCT (SET), AILERON THERAPEUTICS INC (NASDAQ), ENTERA BIO LTD (NASDAQ), MILLENDO THERAPEUTICS INC (NASDAQ), EXTRAWELL PHAR (HKEx), ACER THERAPEUTICS INC (NASDAQ), PDS BIOTECHNOLOGY CORPORATION (NASDAQ), CNS PHARMACEUTICALS INC (NASDAQ), MEDLAB CLINICAL LIMITED (ASX), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), TITAN PHARMACEUTICAL INC (NASDAQ), IMMURON LIMITED (ASX), PHARMAXIS (ASX), TIMBER PHARMACEUTICALS INC (NYSE American), SPRING BANK PHARMACEUTICALS INC (NASDAQ), BRICKELL BIOTECH INC (NASDAQ), SINOLIFE UTD (HKEx), EXOPHARM LTD (ASX), PROPHASE LABS INC (NASDAQ), ACRUX (ASX), ADIAL PHARMACEUTICALS INC (NASDAQ), PASHUN INT'L (HKEx), TELIGENT INC NEW (NASDAQ), TALI DIGITAL LIMITED (ASX), CHINA SXT PHARMACEUTICALS INC (NASDAQ), CELLMID LIMITED (ASX), CRESO PHARMA LTD (ASX), Merck Sharp Dohme Pharma Tbk. (IDX), NOVUS THERAPEUTICS INC (NASDAQ), SUDA PHARMACEUTICALS LTD (ASX), FARMAFORCE LTD (ASX), Pharmesis Intl (SGX), FIJI KAVA LTD (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.060
+8.51 %
10 Days -+0.100
+15.04 %
20 Days -+0.070
+10.07 %
Medium Term Return 3 Months -+0.235
+44.34 %
6 Months 0.006+0.235
+45.47 %
1 Year 0.012+0.315
+72.67 %
Annualised Return Annualised --
+72.67 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.340 - 0.830 Change From 1 Year Low +0.425 % Change From 1 Year Low (%) +125.00
Change From 1 Year High -0.065 % Change From 1 Year High (%) -7.83
2 Years Range 0.280 - 0.830 Change From 2 Years Low +0.485 % Change From 2 Years Low (%) +173.21
Change From 2 Years High -0.065 % Change From 2 Years High (%) -7.83
5 Years Range 0.280 - 0.830 Change From 5 Years Low +0.485 % Change From 5 Years Low (%) +173.21
Change From 5 Years High -0.065 % Change From 5 Years High (%) -7.83
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

IPO Performance

Listing Date 20 Jul 2018 Full Subscription Rate (x) -
No of Placement Shares (M) 50.66 No of Public Offer Shares (M) 81.66 Public Offer Subscription Rate (x) -
IPO Price (MYR) 0.550 First Day Close (MYR) 0.760 First Week Close (MYR) 0.600
Current vs IPO Price (%) +39.09 First Day Gain (%) +38.18 First Week Gain (%) +9.09

Reports Download

Report Type Financial Year Ended Download
Annual Report
Annual Report 2019 Jun 2019 Part 1(2.27 MB)
Part 2(0.31 MB)

Historical Price Data

Date Open High Low Close Volume VWAP
15 Jul 2020 0.730 0.770 0.730 0.765 2,903,200 0.7568
14 Jul 2020 0.725 0.750 0.720 0.720 2,780,200 0.7391
13 Jul 2020 0.720 0.725 0.715 0.725 1,285,200 0.7213
10 Jul 2020 0.700 0.720 0.695 0.710 957,300 0.7036
09 Jul 2020 0.705 0.705 0.695 0.705 491,500 0.7062
08 Jul 2020 0.720 0.720 0.705 0.705 339,700 0.7349
07 Jul 2020 0.715 0.735 0.710 0.715 1,598,700 0.7197
06 Jul 2020 0.685 0.715 0.670 0.705 2,356,300 0.6916
03 Jul 2020 0.680 0.685 0.660 0.675 975,300 0.6743
02 Jul 2020 0.665 0.670 0.650 0.660 391,100 0.6658
01 Jul 2020 0.650 0.665 0.645 0.665 545,900 0.6550
30 Jun 2020 0.630 0.650 0.630 0.640 1,072,600 0.6458
29 Jun 2020 0.635 0.635 0.595 0.625 1,633,200 0.6150
26 Jun 2020 0.670 0.670 0.635 0.635 796,400 0.6430
25 Jun 2020 0.665 0.665 0.645 0.650 578,000 0.6600
24 Jun 2020 0.675 0.680 0.660 0.660 710,100 0.6849
23 Jun 2020 0.675 0.675 0.660 0.675 545,500 0.7001
22 Jun 2020 0.665 0.690 0.665 0.680 273,600 0.7423
19 Jun 2020 0.690 0.690 0.680 0.680 381,000 0.6924
18 Jun 2020 0.700 0.705 0.680 0.690 844,800 0.7058
17 Jun 2020 0.685 0.695 0.660 0.695 761,100 0.6784
16 Jun 2020 0.660 0.685 0.660 0.685 720,500 0.6799
Summary
Current 2 Weeks
(02 Jul 2020 to 15 Jul 2020)
0.665 0.770 0.650 0.765 14,078,500 -
Previous 2 Weeks
(18 Jun 2020 to 01 Jul 2020)
0.700 0.770 0.650 0.665 7,381,100 -
4 Weeks from
(18 May 2020 to 17 Jun 2020)
0.715 0.770 0.650 0.695 68,940,700 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.